Monday, February 05, 2018 10:15 PM ET
Insider buy at Seattle Genetics (SGEN) is Significant Breaks Selling Trend of Last Quarter
There was a significant insider purchase in Seattle Genetics shares today as revealed in a filing with the SEC. One insider — Baker Bros Advisors Lp, 10% Owner and Director — bought 3,846,153 shares in the company having a net market value of approximately $199,999,956. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 3,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 3,843,153 shares and have averaged 1,924,577 shares per transaction over this time period.
The number of insider buy/sell trades at Seattle Genetics is greater than the 191 peer company average over the last 90-day period. The Biotechnology & Medical Research peer group saw 167 buy/sell trades during this period for an average of 0.9 transactions per company. The number of shares per buy/sell trade for Seattle Genetics insiders was also higher. Within the peer group there were 11,151,510 shares purchased and 12,796,830 shares sold with company insiders having sold 9,852 shares on average.
Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data used in creating and writing this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2018 UpTick Data Technologies. All rights reserved.